Craig Stoltz's SharePosts Health Expert Craig Stoltz shares health management news and commentary at HealthCentral.com. HealthCentral.com is one of the top health destinations on the Web, with more than 35 condition-specific, wellness and general health Web properties. http://www.healthcentral.com/profiles/c/5133/index http://www.healthcentral.com/profiles/c/5133/rss self application/xml en-us 15 Craig Stoltz's SharePosts 120 19 http://www.healthcentral.com/images/hc_logo_sm.gif http://www.healthcentral.com/profiles/c/5133/index http://www.healthcentral.com/prostate/c/5133/28476/proscar-questioned Wed, 21 May 2008 09:48:18 -0400 Craig Stoltz Proscar, Aggressive Tumor Risk Questioned Proscar, a widely used drug used to shrink the prostate, may not cause aggressive prostate cancer tumors after all. Back in 2003, a big government study found that Proscar reduced risk of developing prostate cancer by 25 percent--but appeared to boost the incidence of aggressive, potentially lethal tumors.   Well, five years later doctors have taken a second look at that data and decided Proscar doesn't appear to boost risk of those... http://www.healthcentral.com/prostate/c/5133/28476/proscar-questioned http://www.healthcentral.com/prostate/c/5133/14375/waiting-expected Mon, 01 Oct 2007 08:51:00 -0400 Craig Stoltz Waiting: Perhaps Less of a Stressor Than Expected One of the most persuasive arguments against "watchful waiting"--taking no action on slow-growing prostate cancer contained to the gland until circumstances change--is that the anxiety of knowing there's a cancer down there is too much to bear. A surprising new study shows that, at least in one group of men observed, watchful waiters may not suffer high anxiety. Bottom line first According to a study on prostate cancer... http://www.healthcentral.com/prostate/c/5133/14375/waiting-expected http://www.healthcentral.com/prostate/c/5133/13736/cancer-risk Mon, 17 Sep 2007 17:28:00 -0400 Craig Stoltz Finasteride, Prostate Growth... and Cancer Risk A fascinating study out of the National Cancer Institute has significant implications for men at risk for prostate cancer and men with enlarged prostates--for most men, really. But the study invites possible overinterpretation. Let's parse it carefully. Bottom line first Finasteride, a drug used to treat benign prostatic hyperplasia (non-cancerous prostate enlargement, also known as BPH) has previously been linked to a reduction in... http://www.healthcentral.com/prostate/c/5133/13736/cancer-risk